TSS
SQZ

Two Sigma Securities’s SQZ Biotechnologies Company SQZ Stock Holding History

Two Sigma Securities’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-36,069
Closed -$20.2K – 3537
2023
Q1 		$20.2K Buy
+36,069
New +$26.6K ﹤0.01% 2361

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Securities's SQZ Position: Q2 2023 in Review

Two Sigma Securities sold out of SQZ Biotechnologies Company (SQZ) in Q2 2023, closing a stake of 36,069 shares — an estimated $20.2K sold.

Two Sigma Securities first reported a position in SQZ in Q1 2023 and held it in 1 quarter. The position peaked at $20.2K in Q1 2023. 31 funds tracked by Wall St. Rank hold SQZ as of Q2 2023.

  • Two Sigma Securities reported no remaining SQZ Biotechnologies Company position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 36,069 SQZ Biotechnologies Company shares in Q2 2023, an estimated $20.2K.
  • Two Sigma Securities first reported a position in SQZ Biotechnologies Company in Q1 2023 and held it in 1 quarter.
  • Two Sigma Securities's SQZ Biotechnologies Company position peaked at $20.2K in Q1 2023.
  • 31 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.